{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:53:34Z","timestamp":1762509214234,"version":"3.41.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ajp.2025.104426","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T17:09:55Z","timestamp":1741194595000},"page":"104426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Special issue on \u201cKetamine, MDMA, and psychedelics in the treatment of neuropsychiatric disorders\u201d"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jichun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2025.104426_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2025.104383","article-title":"Sequential ketamine infusion and electroconvulsive therapy in severe depression with psychotic symptoms and pseudo-dementia \u2013 a case report","volume":"104","author":"Arora","year":"2025","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104426_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104242","article-title":"S. Exploring the regulatory framework of psychedelics in the US & Europe","volume":"102","author":"Behera","year":"2024","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104426_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104167","article-title":"Ketamine-dependent patients with persistent psychosis have higher neurofilament light chain levels than patients with schizophrenia","volume":"100","author":"Chung","year":"2024","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104426_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-024-01770-7","article-title":"Are \"mystical experiences\" essential for antidepressant actions of ketamine and the classic psychedelics?","author":"Hashimoto","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ajp.2025.104426_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jatmed.2024.07.001","article-title":"Ketamine and its two enantiomers in anesthesiology and psychiatry: a historical review and future directions","volume":"3","author":"Hashimoto","year":"2024","journal-title":"J. Anest. Transl. Med."},{"key":"10.1016\/j.ajp.2025.104426_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104164","article-title":"Potential effect of ketamine in treatment for dextromethorphan use disorder exploding in Japanese young population","volume":"99","author":"Ishii","year":"2024","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104426_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.103997","article-title":"Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: a meta-analysis of randomized controlled trials","volume":"95","author":"Lou","year":"2024","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104426_bib8","article-title":"Ketamine: an emerging agent in the management of neuropsychiatric disorders","author":"Menke","year":"2024","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104426_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104159","article-title":"Treatment-emergent symptoms during short-term ketamine administration in treatment-resistant bipolar depression: a retrospective cross-sectional descriptive study","volume":"99","author":"Pastuszak","year":"2024","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104426_bib10","article-title":"Systematic review of parenteral ketamine for managing acute agitation in emergency settings","volume":"103","author":"Peter","year":"2024","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104426_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104246","article-title":"Therapeutic potential of ketamine in management of epilepsy: clinical implications and mechanistic insights","volume":"101","author":"Tan","year":"2024","journal-title":"Asian J. Psychiatry"},{"issue":"1","key":"10.1016\/j.ajp.2025.104426_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104426_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104016","article-title":"Single arketamine in treatment resistant depression: presentation of 3 cases with regard to sick-leave duration","volume":"96","author":"W\u0142odarczyk","year":"2024","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104426_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109219","article-title":"Arketamine, a new rapid-acting antidepressant: a historical review and future directions","volume":"218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ajp.2025.104426_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104193","article-title":"Psychoactive substances for the treatment of neuropsychiatric disorders","volume":"101","author":"Zhen","year":"2024","journal-title":"Asian J. Psychiatry"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201825000693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201825000693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T03:14:35Z","timestamp":1748402075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201825000693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":15,"alternative-id":["S1876201825000693"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2025.104426","relation":{},"ISSN":["1876-2018"],"issn-type":[{"type":"print","value":"1876-2018"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Special issue on \u201cKetamine, MDMA, and psychedelics in the treatment of neuropsychiatric disorders\u201d","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2025.104426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104426"}}